Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 Nov 4;30:346. doi: 10.1016/j.omtn.2022.10.020

Retraction Notice to: Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma

Yi Hou, Li Fan, Hai Li
PMCID: PMC9641254  PMID: 36381586

Main text

(Molecular Therapy: Nucleic Acids 24, 92-103; June, 2021)

This article has been retracted at the request of the editor-in-chief. Similarities were reported between images in this article and an article previously published by unrelated authors in Cell Communication and Signaling (Shang et al., 2020, Cell Comm. Signal. 52, https://doi.org/10.1186/s12964-020-0517-1). These concerns were initially reported in a Pubpeer thread (https://pubpeer.com/publications/1B4308B780AED6692628A98EAAD7D4). Image analysis performed by the editorial office confirmed the findings of image duplication in Figure 4A of the Molecular Therapy - Nucleic Acids article. This reuse (and in part misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The editorial office was unable to reach the corresponding author, and no other authors responded.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES